Ladenburg Thalmann Upgrades Repros Therapeutics (RPRX) to Buy

November 16, 2016 7:53 AM EST
Get Alerts RPRX Hot Sheet
Price: $1.51 -1.95%

Rating Summary:
    4 Buy, 2 Hold, 1 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 21 | Down: 36 | New: 11
Trade RPRX Now!
Join SI Premium – FREE

News and research before you hear about it on CNBC and others. Claim your 2-week free trial to StreetInsider Premium here.

Ladenburg Thalmann upgraded Repros Therapeutics (NASDAQ: RPRX) from Neutral to Buy with a price target of $5.50.

For an analyst ratings summary and ratings history on Repros Therapeutics click here. For more ratings news on Repros Therapeutics click here.

Shares of Repros Therapeutics closed at $1.88 yesterday.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories

Hot Upgrades, Upgrades

Related Entities

Ladenburg Thalmann Financial Services

Add Your Comment